Prevalence of Dyslipidemia and Associated Risk Factors Among Newly Diagnosed Type-2 Diabetes Mellitus (T2DM) Patients in Kushtia, Bangladesh

Overview

Journal PLOS Glob Public Health

Specialty Public Health

Date 2023 Mar 24

PMID 36962092

Authors

Md Saad Ahmmed

Suvasish Das Shuvo

Dipak Kumar Paul

M R Karim

Md Kamruzzaman

Niaz Mahmud

Md Jannatul Ferdaus

Md Toufiq Elahi

Affiliations

Soon will be listed here.

Abstract

Dyslipidemia is considered a significant modifiable risk factor for type-2 diabetes mellitus (T2DM) and has become one of the emerging health problems throughout the world. In Bangladesh, data on dyslipidemia among newly diagnosed T2DM patients are comparatively inadequate. This study aimed to evaluate the prevalence of dyslipidemia and its associated risk factors in newly diagnosed T2DM patients. This cross-sectional study was conducted by a well-structured questionnaire from 132 newly diagnosed type-2 diabetic patients attending the Mujibur Rahman Memorial Diabetic Hospital in Kushtia, Bangladesh. Data regarding socio-demographic, anthropometric, fasting blood glucose, total cholesterol (TC), triglyceride (TG), high-density lipoprotein (HDL), and low-density lipoprotein (LDL) were collected from all the respondents. The association between dyslipidemia and its associated factors was analyzed using the multivariate logit regression model. The findings suggest that the prevalence rate of dyslipidemia was 75.7% in female and 72.6% in male T2DM patients. The odds of having dyslipidemia were 1.74 (95% Cl: 1.58-1.87) times significantly higher in female (p<0.001). The other factors associated with dyslipidemia encompassed age between 30-39 years (OR: 2.32, 95% CI: 1.97-2.69), obesity (OR: 2.63, 95% CI: 2.27-2.90), waist circumferences of male ≥90 and female ≥80 (OR: 1.65, 95% CI: 1.59-1.89), hypertensive patients (OR: 1.51, 95% CI: 1.45-1.74), physically inactive (OR: 3.25, 95% CI: 1.84-4.68), and current smoker or tobacco user (OR: 1.93, 95% CI: 1.85-2.13). This study concluded that the high prevalence of dyslipidemia was found among newly diagnosed type-2 diabetes patients and associated with gender, age, BMI, waist circumference, poor physical activity, and smoking, or tobacco use. This result will support increase awareness of dyslipidemia and its associated risk factors among type-2 diabetes patients.

Citing Articles

A predictive model to assess the risk of developing hyperlipidemia in patients with type 2 diabetes.

Ye R, Huang X, Yang H, Pan W, Wang P, Men J PLoS One. 2025; 20(2):e0315781.

PMID: 39951410 PMC: 11828393. DOI: 10.1371/journal.pone.0315781.

Frequency and pattern of dyslipidemia and its association with other risk factors among Type-2 Diabetics.

Muhammad A, Afzaal M, Khan M, Baig A, Aasim M Pak J Med Sci. 2025; 41(2):472-477.

PMID: 39926650 PMC: 11803807. DOI: 10.12669/pjms.41.2.10264.

Associations Between Body Mass Index (BMI) and Dyslipidemia: Results From the PERSIAN Guilan Cohort Study (PGCS).

Shahraz J, Joukar F, Sheida F, Yeganeh S, Maroufizadeh S, Baghaee M Obes Sci Pract. 2025; 11(1):e70055.

PMID: 39917550 PMC: 11802237. DOI: 10.1002/osp4.70055.

Patterns and Factors Associated with Dyslipidemia Among Patients with Diabetes Mellitus Attending Hoima Regional Referral Hospital, Uganda.

Hirsi A, Abdi A, Peris A, Jacinto A, Muhammad P, Nur I Int J Gen Med. 2025; 18():73-86.

PMID: 39801925 PMC: 11725251. DOI: 10.2147/IJGM.S494941.

Dyslipidemia and associated factors among adult type two diabetes mellitus patients in Felege Hiywot Refral, Hospital, Bahir Dar, Ethiopia, 2023.

Addis Z, Nega A, Tebeje R, Asmare E, Tegegnie A, Tamir W Front Cardiovasc Med. 2025; 11:1493447.

PMID: 39759497 PMC: 11695342. DOI: 10.3389/fcvm.2024.1493447.

References

Alzaheb R, Altemani A . Prevalence and Associated Factors of Dyslipidemia Among Adults with Type 2 Diabetes Mellitus in Saudi Arabia. Diabetes Metab Syndr Obes. 2020; 13:4033-4040. PMC: 7604430. DOI: 10.2147/DMSO.S246068. View

Zheng Y, Ley S, Hu F . Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2017; 14(2):88-98. DOI: 10.1038/nrendo.2017.151. View

Muntner P, Carey R, Gidding S, Jones D, Taler S, Wright Jr J . Potential U.S. Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline. J Am Coll Cardiol. 2017; 71(2):109-118. PMC: 5873591. DOI: 10.1016/j.jacc.2017.10.073. View

Sheth J, Shah A, Sheth F, Trivedi S, Nabar N, Shah N . The association of dyslipidemia and obesity with glycated hemoglobin. Clin Diabetes Endocrinol. 2017; 1:6. PMC: 5469195. DOI: 10.1186/s40842-015-0004-6. View

Yu S, Yang H, Guo X, Zhang X, Zheng L, Sun Y . Prevalence of dyslipidemia and associated factors among the hypertensive population from rural Northeast China. BMC Public Health. 2015; 15:1152. PMC: 4654887. DOI: 10.1186/s12889-015-2486-7. View

Das H, Banik S . Prevalence of dyslipidemia among the diabetic patients in southern Bangladesh: A cross-sectional study. Diabetes Metab Syndr. 2019; 13(1):252-257. DOI: 10.1016/j.dsx.2018.09.006. View

Sharma U, Kishore J, Garg A, Anand T, Chakraborty M, Lali P . Dyslipidemia and associated risk factors in a resettlement colony of Delhi. J Clin Lipidol. 2013; 7(6):653-60. DOI: 10.1016/j.jacl.2013.06.003. View

Mooradian A . Dyslipidemia in type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab. 2009; 5(3):150-9. DOI: 10.1038/ncpendmet1066. View

Najafipour H, Shokoohi M, Yousefzadeh G, Sarvar Azimzadeh B, Moshtaghi Kashanian G, Bagheri M . Prevalence of dyslipidemia and its association with other coronary artery disease risk factors among urban population in Southeast of Iran: results of the Kerman coronary artery disease risk factors study (KERCADRS). J Diabetes Metab Disord. 2016; 15:49. PMC: 5073446. DOI: 10.1186/s40200-016-0268-0. View

10.

Feher M . Diabetes: preventing coronary heart disease in a high risk group. Heart. 2004; 90 Suppl 4:iv18-21. PMC: 1876314. DOI: 10.1136/hrt.2004.037572. View

11.

Sonne D, Hemmingsen B . Comment on American Diabetes Association. . Diabetes Care 2017;40(Suppl. 1):S1-S135. Diabetes Care. 2017; 40(7):e92-e93. DOI: 10.2337/dc17-0299. View

12.

Bayram F, Kocer D, Gundogan K, Kaya A, Demir O, Coskun R . Prevalence of dyslipidemia and associated risk factors in Turkish adults. J Clin Lipidol. 2014; 8(2):206-16. DOI: 10.1016/j.jacl.2013.12.011. View

13.

Taskinen M . Diabetic dyslipidemia. Atheroscler Suppl. 2002; 3(1):47-51. DOI: 10.1016/s1567-5688(01)00006-x. View

14.

Wilson P, DAgostino R, Levy D, Belanger A, Silbershatz H, Kannel W . Prediction of coronary heart disease using risk factor categories. Circulation. 1998; 97(18):1837-47. DOI: 10.1161/01.cir.97.18.1837. View

15.

Qi L, Ding X, Tang W, Li Q, Mao D, Wang Y . Prevalence and Risk Factors Associated with Dyslipidemia in Chongqing, China. Int J Environ Res Public Health. 2015; 12(10):13455-65. PMC: 4627042. DOI: 10.3390/ijerph121013455. View

16.

Wilson P, DAgostino R, Parise H, Sullivan L, Meigs J . Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005; 112(20):3066-72. DOI: 10.1161/CIRCULATIONAHA.105.539528. View

17.

Narindrarangkura P, Bosl W, Rangsin R, Hatthachote P . Prevalence of dyslipidemia associated with complications in diabetic patients: a nationwide study in Thailand. Lipids Health Dis. 2019; 18(1):90. PMC: 6451778. DOI: 10.1186/s12944-019-1034-3. View

18.

Lee M, Ahn S, Hur N, Choi D, Kim H, Suh I . Gender differences in the association between smoking and dyslipidemia: 2005 Korean National Health and Nutrition Examination Survey. Clin Chim Acta. 2011; 412(17-18):1600-5. DOI: 10.1016/j.cca.2011.05.013. View

19.

Khan H, Sobki S, Khan S . Association between glycaemic control and serum lipids profile in type 2 diabetic patients: HbA1c predicts dyslipidaemia. Clin Exp Med. 2007; 7(1):24-9. DOI: 10.1007/s10238-007-0121-3. View

20.

Tan X, Jiao G, Ren Y, Gao X, Ding Y, Wang X . Relationship between smoking and dyslipidemia in western Chinese elderly males. J Clin Lab Anal. 2008; 22(3):159-63. PMC: 6649235. DOI: 10.1002/jcla.20235. View